Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
The Journal of Pathology|December 6, 2013
The genomic landscape of oesophagogastric junctional adenocarcinomaIrene Y Chong, David Cunningham, Louise J Barber, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C TrialGayathri Anandappa, Andrea Lampis, David Cunningham, et al.Oncotarget|October 15, 2017
Molecular profiling of colorectal pulmonary metastases and primary tumours: implications for targeted treatmentSing Y Moorcraft, Thomas Jones, Brian A Walker, et al.Journal for Immunotherapy of Cancer|April 16, 2019
CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoidsReyes Gonzalez-Exposito, Maria Semiannikova, Beatrice Griffiths, et al.BMJ Health & Care Informatics|September 22, 2025
Supporting cancer research on real-world data: extracting colorectal cancer status and explicitly written TNM stages from free-text imaging and histopathology reportsAndres Tamm, Helen J S Jones, Neel Doshi, et al.JCO Precision Oncology|October 5, 2020
Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 TrialElisa Fontana, Gift Nyamundanda, David Cunningham, et al.BMJ Health & Care Informatics|June 23, 2022
Establishing a colorectal cancer research database from routinely collected health data: the process and potential from a pilot studyAndres Tamm, Helen Js Jones, William Perry, et al.Clinical Chemistry|August 29, 2018
Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA SequencingSonia Mansukhani, Louise J Barber, Dimitrios Kleftogiannis, et al.Gut|August 10, 2017
Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II studyKhurum Khan, Mihaela Rata, David Cunningham, et al.Gut|November 17, 2020
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancersElizabeth C Smyth, Georgios Vlachogiannis, Somaieh Hedayat, et al.Pageof 13